JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Compared with JAK2 mutations, JAK2 fusions are probably associated with more aggressive diseases such as acute leukemias (myeloid or lymphoblastic), atypical CML (aCML), and myelofibrosis [9].